跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,456 条关于
“MSN Labs”
全部
6,456
临床试验
4,555
药物
681
机构
179
资讯
1,041
11个月前
MSN Labs Receives Regulatory Approval for Phase III Trial of Vibegron 75 mg in Overactive Bladder
去年
Major Pharmaceutical Companies Face Surge in Generic Drug Patent Challenges in Early 2025
去年
Indian Patent Office Revokes Novartis' Vymada Patent, Opening Door for Generic Competition
7个月前
Major Pharmaceutical Patent Litigation Wave Intensifies in Q4 2025 as Generic Manufacturers Challenge Key Drug Patents
4个月前
Indian Patent Office Rejects AbbVie Patents for Rinvoq and Maviret, Clearing Path for Generic Competition
去年
Allchem Lifescience Files for IPO to Raise ₹190 Crore, Expands API Manufacturing Capabilities
去年
Indian SEC Recommends Approval for MSN Laboratories' Pitolisant for Narcolepsy
去年
Novartis and MSN Settle Entresto Patent Dispute, Boosting Divi's Laboratories Outlook
去年
Federal Courts Block MSN Laboratories' Early Launch of Generic Entresto Until July 2025
去年
Esperion Secures Patent Protection for NEXLETOL Until 2040 Through Settlement with Micro Labs
第 1 页,共 105 页
上一页
下一页